Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Oriza Ventures

Investor type Micro VC
Founders Alex Liang John Yu

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 49
Average round size
info
The average size of a deal this fund participated in
$8M
Portfolio companies 44
Rounds per year 6.12
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.10
Exits 4
Key employees 2
Stages of investment
Early Stage Venture
Seed

Areas of investment

  • Software
  • Biotechnology
  • Artificial Intelligence
  • Mobile
  • Machine Learning
Summary

Oriza Ventures appeared to be the VC, which was created in 2015. The main office of represented VC is situated in the Santa Clara. The company was established in North America in United States.

Among the most popular portfolio startups of the fund, we may highlight Atrium LTS, Drive.ai, Bolt. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. The fund has no exact preference in some founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. Among the most popular fund investment industries, there are Software, Mobile.

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Oriza Ventures, startups are often financed by ff Venture Capital, Correlation Ventures, Voyager Capital. The meaningful sponsors for the fund in investment in the same round are Northern Light Venture Capital, StartX (Stanford-StartX Fund), Plug and Play. In the next rounds fund is usually obtained by Plug and Play, StartX (Stanford-StartX Fund), Samsung NEXT.

Deals in the range of 10 - 50 millions dollars are the general things for fund. The higher amount of exits for fund were in 2019. The top activity for fund was in 2016. The average startup value when the investment from Oriza Ventures is 100-500 millions dollars. This Oriza Ventures works on 23 percentage points less the average amount of lead investments comparing to the other organizations. The fund is constantly included in 2-6 deals per year.

We also calculated 2 valuable employees in our database.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Oriza Ventures:
Typical Co-investors
Oriza Ventures is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Oriza Ventures:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Aiche Technology Beijing, Beijing, China
alumshares North Carolina, Raleigh, United States
Avera Pharmaceutical California, Carlsbad, United States
Baxalta Illinois, Illinois City, United States
Cazador Acquisition Corporation Ltd Bulgaria, Grad Sofiya, Sofia
Circularity Capital City of Edinburgh, Scotland, United Kingdom
CommIT Capital Moscow, Moscow, Russia
Escondido Ventures San Antonio, Texas, United States
Fresh VC California, San Francisco, United States
ICS Global Michigan, Rochester, United States
Les Crudettes -
Muzhitong Technology China, Hubei, Wuhan
Newlight Partners New York, New York, United States
Patient Autonome -
SMW Capital -
Splunk California, San Francisco, United States
Star Power Canada, Ontario, Toronto
Sycamore Ventures New Jersey, Princeton, United States
Webforia Bellevue, United States, Washington

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Mila

Application Software
Collaborative Consumption
Crowdsourcing
EdTech
Health Care
Information Services (B2C)
Location Based Services
Mobile
Social/Platform Software
Software
$2M07 Jun 2022 Berlin, Berlin, Germany

Unifimoney

Financial Services
FinTech
$10M06 Apr 2022 San Francisco, California, United States

Parade

Enterprise Applications
Logistics
Mobile Apps
Transportation
$12M08 Feb 2022 San Francisco, California, United States

Lifo

Social Shopping
Software
$3M01 Dec 2021 Mountain View, California, United States

Impulse Technology

Artificial Intelligence
Blockchain
Cloud Data Services
17 Aug 2021 Shanghai, Shanghai, China

Jerry

Artificial Intelligence
Auto Insurance
Automotive
Finance
Financial Services
FinTech
Insurance
InsurTech
$9M17 May 2021 Palo Alto, California, United States

Electronics
Semiconductor
$100M06 Apr 2021 Shanghai, China

Teon Therapeutics

Biopharma
Biotechnology
Pharmaceutical
$30M23 Feb 2021 Redwood City, California, United States

APstem Therapeutics, Inc.

Biotechnology
Health Care
Life Science
$2M01 Sep 2020 Fremont, California, United States
News
Teon Therapeutics Completes $30 Million Series A Financing

– Teon Therapeutics completed a $30m Series A financing.
– The financing was led by Oceanpine Capital with participation from additional new investors Oriza Ventures, Lifespan Investments, and former Gilead senior executives.
– All existing investors also participated in the financing round including Northern Light Venture Capital, Kaitai Capital and Oriental Fortune Capital.
– The funds will be used to advance the company’s lead A2BR-selective antagonist TT-702 into the clinic as well as to build the company’s pipeline.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Oriza Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: